Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03220477 |
|---|---|
| Brief Title: | Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer. |
| First Submitted : | July 14, 2017 |
| First Submitted that Met QC Criteria : | July 14, 2017 |
| First Posted : | July 18, 2017 |
| Last Update Submitted that Met QC Criteria : | December 13, 2022 |
| Last Update Posted : | December 15, 2022 |